We provide you with 20 years of free, institutional-grade data for MIST stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MIST. Explore the full financial landscape of MIST stock.
| Reported Date | CIK | Ticker | Type |
|---|
Milestone Pharmaceuticals Inc(NASDAQ:MIST) 
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the Uni...
Website: http://www.milestonepharma.com
Full Time Employees: 28
CEO: Joseph G. Oliveto
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about MIST stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.